Apexium Financial »

Recursion Pharmaceuticals shares owned by Apexium Financial

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Apexium Financial from 13F filings

Historical chart of Apexium Financial investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Apexium Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Apexium Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $82k 17k 4.88
2025-06-30 $80k 16k 5.06

More positions owned by Apexium Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Advisor Managed Portfolios Soundwatch Hedgd (SHDG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr U.s. Tech Etf (IYW)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Apexium Financial

Top funds holding Recursion Pharmaceuticals

Vanguard Group
ARK Investment Management
BlackRock
Baillie Gifford & Co
State Street Corporation
Softbank Group Corp
Kinnevik AB
Mubadala Investment Co PJSC
MIC Capital Management UK
Geode Capital Management
Susquehanna International
Novo A/S
Nvidia Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Recursion Pharmaceuticals